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 Figure 2. Gamma index analysis results for (a) pelvis and (b) head-
and-neck cases 
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Conclusions: The presence of intravenous contrast agent does not 
significantly affect the dose calculation in CT-based 3D-CRT planning 
of pelvis and head-and-neck.  
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Purpose/Objective: The dosimetric aspects of radiotherapy treatment 
plan quality are evaluated with isodoses and dose volume histogram 
(DVH) values. Usually, the reporting consists in some particular values 
for target volumes (TV) and organs at risk (OAR). However, due to the 
complexity of the IMRT dose distributions, given a patient and 
treatment goals, several operators produce their own optimal plan 
depending on their experience and their tradeoffs between TV and 
OAR DVH endpoints. The aim of this study was (1) to evaluate the 
operator variability in our institution and (2) to improve the relevancy 
of the DVH endpoints. The study focused on Tomotherapy planning for 
head and neck cases. 
Materials and Methods: Ten patients with bilateral lymphatic node 
irradiation were selected from our database. Prescribed doses for 
planning target volumes PTV(tumor) and lymphatic nodes PTV(nodes) 
were 70Gy and 56Gy in 35 fractions respectively. For each patient, 
seven physicists of our department produced their own plan based on 
the same set of contours and the same treatment goals. For plan 
validation, DVH endpoints were related to the following organs: GTV 
(D98%), PTV(tumor) (D98%, D2%), PTV(nodes) D(98%), spinal cord 
(D2%), parotid glands (Dmean, V45Gy, V30Gy), larynx (V50Gy), oral 
cavity(V50Gy). The inter-operator variability was studied by 
comparing the DVH values. Three groups of values were evaluated (i) 
PTVs, (ii) principal OARs for which the respect of endpoints is 
mandatory and (iii) secondary OARs for which the respect of endpoints 
improves the patient quality of life. 
Results: Physicists had an experience with Tomotherapy planning 
software ranging from 1 to 5 years. 70 plans were generated and were 
evaluated by a single physician. For all patients, all plans were 
clinically acceptable despite some discrepancies. For group (i), the 
main difference concerned D98% for PTV(tumor) and PTV(nodes) that 
were lower for two planners. For group (ii), the D2% to the spinal cord 
never exceeded 38Gy. Large differences were observed but they were 
considered minor by the physician. For group (iii), experience and 
tradeoffs of the planners yielded different dosimetric results, 
especially in the larynx and in the ipsilateral parotid gland. This organ 
sparing can lead to an slight undercoverage of the PTV(tumor). 
Whatever the group, differences were particularly observed for the 
first patients studied, but were reduced during the study. 
Conclusions: This work showed inter-operator variability in 
Tomotherapy planning for head and neck cases. However, all plans 
were acceptable by the physician. This comparison allowed to better 
define the priority of the endpoints to evaluate the quality of a plan 
and to narrow the variability over the study.  
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Purpose/Objective: Volumetric-modulated arc therapy (VMAT) is a 
relatively new treatment modality, in which gantry rotation and 
speed, dose-rate and multileaf collimator (MLC) leaves motion vary 
simultaneously. The aim of the study was to compare conventional 
intensity modulated radiation therapy (IMRT) with VMAT plans for 
prostate cancers. 
Materials and Methods: Ten randomly selected patients with prostate 
cancer were included for the present study. Contours for each pts 
were drawn using our clinical protocol. For each patient, three plans 
were generated for treatment modalities using a 80 leaves MLC with 
the leaves of 10 mm (MLCi2 Elekta Synergy). All IMRT and VMAT plans 
were calculated for 6MV photons. IMRT plan were generated using 
Oncentra Master Plan (v 3.3), whereas VMAT plans were performed 
with Monaco (v 3.2). The dose prescription was 76 Gy in 38 fractions 
to the target volume with respect the dose volume criteria for the 
organ at risk (OAR) complied with QUANTEC recommendation. Dose-
volume parameters of the plans were evaluated according to Rapport 
ICRU No 81.  
Results: All techniques: IMRT as well as VMAT result in treatment 
plans which comply with our current applied clinical protocol. From 
the DVH data, target coverage achieved similar results for IMRT and 
VMAT (table1): V95% - 99,3±0,7% and 99,2±0,7% for IMRT and VMAT, 
respectively. The average dose were 102,5±3,2% for IMRT and 
102,4±3,3% for VMAT. For OAR all planning objectives were largely 
met. VMAT plans were superior for rectum in all dose-volume 
constraints (p<0.05). Similar results were achieved in dose-volume 
constraints for bladder. VMAT leads to the average reduction of about 
6 Gy for the mean dose for rectum and of about 11 Gy for mean dose 
for bladder comparing to IMRT. There were no statistical differences 
between IMRT and VMAT in mean and dose-volume parameters for 
femurs. The average MU were 452±.81,7, and 510.9±.50,6for IMRT and 
VMAT, respectively. 
Conclusions: VMAT achieved similar target coverage to IMRT plans for 
prostate cancer pts. It provided a better OAR sparing due to reduction 
of high-dose-receiving area of healthy tissue. Further studies are 
indicated to evaluated the VMAT impact on quality of life of prostate 
cancer pts during and after the therapy. 
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Purpose/Objective: The extended volume irradiation, in pelvis or 
para-aortic volumes, presents some technique and dosimetrical 
difficulties when performed with 3D-CRT due to the junction and the 
presence of critical upper abdominal structures. Compared with 3D-
CRT, Helical Tomotherapy (HT) delivers an highly conformal dose 
distribution with the possibility to treat extended fields (EF) without 
junctions. The aim of this work is to evaluate the EF technical 
feasibility and safety in Tomotherapy, to optimize the treatment 
planning parameters minimizing dose constraints. Dosimetrical data 
and early toxicities were evaluated. 
Materials and Methods: 31 patients, suitable to EF-IMRT for local 
disease and/or nodal disease on pelvic or lumbar-aortic area, were 
treated and analyzed. The prescription dose was 50.4/54 Gy (1.7-1.8 
Gy/die) for prophylactic lymph nodes (N-) and 60-66 Gy (2-2.2 Gy/die) 
for clinically evident gross disease in the pelvic or para-aortic chain 
(N+). The better parameters, in terms of modulation factor (MF), 
pitch and field width (FW) have been considered to optimize dose 
distribution and treatment time duration. DVH values were analysed 
in terms of D95, average dose for the PTVs and mean and maximum 
dose for OARs. The length of the treatment field, the N+ and N- 
volumes and the time of irradiation were also evaluated. The V5, V10, 
V15 of body was also calculated in order to evaluate the impact of low 
doses. To correlate the dose values to the safety of treatment, 
hematological, hepatic, renal and pancreatic functions were 
evaluated before, during and after treatment. Acute upper 
gastrointestinal (u-GI) and hematological toxicity were evaluated by 
RTOG scale. Hepatic, renal and pancreatic functions were evaluated 
by changes in serological parameters. 
Results: The mean FW, pitch, effective MF and gantry period were 2.5 
cm, 0.287, 1.8 and 13.5 s respectively. The average length of 
treatment was 31.7 cm. Mean irradiation was 10.8 minutes. Average 
values of D95% for PTVs was 96.5%, ranging between 94 and 98%. D95% of 
PTV N+ ranged between 55.1 and 67 Gy. Doses to OARs are reported in 
the table. The treatment was well tolerated, without schedule 
interruption. Ten patients (pts) experienced G1 GI toxicity and 3 pts 
G2 toxicity. Hematological toxicity was G1 in 6 pts, G2 in 4 pts (2 
received concomitant chemotherapy), G3 in 3 pts (all received 
concomitant chemotherapy). In 3 pts we observed a modest increase 
of pancreatic function and in 4 of liver function. There were no 
changes in renal function parameters. 
 
Conclusions: With our treatment design and dose schedule, we found 
that EF- IMRT by Tomotherapy could be safely with a good dose 
distribution and effectively delivered with minimal toxicity in the 
upper abdomen area.  
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Purpose/Objective: Prostate (P) is one of the treatment sites that is 
well suited for IMRT. However, radiation induced complications such 
as urinary incontinence and rectal bleeding are some of the side 
effects. The purpose of this study is to illustrate a protocol for P and P 
with seminal vesicles (P&SV) IMRT plan with step and shoot tecnique 
and Inverse Planning process (Pinnacle3 TPS) to conform the higher 
doses to target and to spare the more sensitive structures in the close 
proximity of the target. 
Materials and Methods: The PTV1 is the P CTV with the addition of 
1cm in all directions except 0.5 cm posteriorly.The PTV2 is the SV 
with the addition of the same margin and PTV1 removed from it. 
Rectum, femoral head, Bladder, anal canal are typical OARs. To force 
the dose distribution to better conform to the target, a shell ROI (1 
cm thick) is created around targets. To reduce high dose regions 
outside the target volumes the RVR ROI iscreated, which consists of 
external patient contour, 0.5 cm contracted, avoiding targets, shell 
and OARs. The isocenter is placed in the center of targets. Five 15 MV 
beams are used (gantry 180°, 255°, 325°, 35°, 105° and collimator 
0°,10°, 10°, 10°, 10°). The couch rotation is set at 0°. Using an odd 
number of beams makes it easier to avoid creating opposing beams. : 
The dose prescription for PTV1 is 74.25 Gy in 33 fr. (2.25 Gy single fr.) 
and for PTV2 is 62.04 Gy in 33 fr. (1.88 Gy). A SIB IMRT technique is 
used in P&SV plan. As a starting point the dose volume objectives, are 
used as in table.The objectives and objectives weights (relative 
importance) can be modified to obtain more satisfactory dose 
distributions. Each beam is optimized using DMPO (Direct Machine 
Parameter Optimization). The max number of iterations is 40, the 
maximum number of segments is 25 (P) or 35 (P&SV), the minimum 
segment area is 10 cm2(P) or 8cm2(P&SV). The final calculation of 
dose is performed with the Adaptive Convolve dose engine and 
0.2x0.2x0.2 cm3grid. 
 
 
Results: 10 (5 P, 5 P&SV) IMRT treatment plans were analyzed. The 
total mean D2%,D50% and D98% of PTV1 and PTV2 are (76.8 ± 0.9) Gy, 
(76.8 ± 0.9) Gy, (68.9 ± 2.0) Gy and (71.2 ± 0.6) Gy, (65.6 ± 1.4) Gy, 
(58.4 ± 1.9) Gy respectively. D50% of PTV2 is slightly larger because 
PTV2 is adjacent to PTV1. The total mean dose and HI of PTV1 and 
PTV2 are (74.1 ± 0.1) Gy, 0.11 ± 0.03 and (64.3 ±1.7) Gy, 0.20 ±0.02 
respectively. PTV2 HI are higher due to the proximity of rectum and 
PTV1. Small regions of high or low absorbed dose inside the target 
may develop when avoidance of neighboring sensitive structures is 
considered more important than high PTV dose homogeneity. Not only 
the required limits for OARs are respected but organ dose and 
expected toxicity are reduced. 
Conclusions: From the results obtained it can be said that the 
protocol of prostate IMRT plan with 'step and shoot' tecnique and 
Inverse Planning process is to be considered valid for increasing target 
dose and reducing toxicity in OARs.  
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Purpose/Objective: In volumetric modulated radiation therapy 
(VMAT) for Head and Neck (H&N) cancer, the dose distribution is 
complicated because of the large radiation field. Therefore the 
number of arc, collimator angle and the maximum leaf-speed are 
significant parameters for irradiating the radiation accurately. The 
purpose of our study is to ensure the influence of these parameters 
for reproducing dose distribution between treatment planning system 
(TPS) and actual dose in patient.  
Materials and Methods: Nineteen VMAT plans for third grade H&N 
cancers were created by Varian Eclipse TPS version.8.9. The 
prescription dose with 70 Gy per 35 fractions was adopted for all 
plans. The dose tolerance was based on RTOG0615. For comparison, 
the collimator angle and leaf-speed were changed for all plans by use 
